Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,381 shares of the biotechnology company’s stock after purchasing an additional 165 shares during the period. Banque Cantonale Vaudoise’s holdings in Axon Enterprise were worth $2,950,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the company. Quent Capital LLC grew its holdings in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares in the last quarter. Blue Trust Inc. grew its stake in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares in the last quarter. Planning Capital Management Corp increased its holdings in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the period. Friedenthal Financial bought a new stake in shares of Axon Enterprise during the third quarter valued at about $51,000. Finally, Reston Wealth Management LLC acquired a new stake in Axon Enterprise in the third quarter worth about $60,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. Barclays boosted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Craig Hallum upped their target price on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. The Goldman Sachs Group lifted their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Robert W. Baird boosted their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, Northland Securities raised their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $427.83.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jeri Williams sold 110 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $400.00, for a total value of $44,000.00. Following the completion of the sale, the director now owns 1,934 shares of the company’s stock, valued at $773,600. The trade was a 5.38 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 410,556 shares of company stock valued at $161,192,754 over the last ninety days. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ AXON opened at $610.20 on Wednesday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1 year low of $224.16 and a 1 year high of $624.84. The company has a market cap of $46.53 billion, a PE ratio of 157.67, a PEG ratio of 15.05 and a beta of 0.94. The stock’s 50-day moving average price is $448.52 and its two-hundred day moving average price is $361.95.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.